Back to search

Article

GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertension

2020-06-19

Abstract excerpt

<h4>SUMMARY</h4> Glaucoma is the leading cause of irreversible blindness worldwide and is characterized by the death of retinal ganglion cells. Reduction of intraocular pressure (IOP) is the only therapeutic mechanism available to slow disease progression. However, glaucoma can continue to progress despite normalization of IOP. New treatments are needed to reduce vision loss and improve outcomes for patients who...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6274d0cb-665c-5f3e-8081-9d94c4adbcf8
DOI
10.1101/2020.06.18.146720
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertensionDOI 10.1101/2020.06.18.146720
Select a neighboring publication to make it the new centre.